[1]
K. S. Atchia, C. J. Wallis, N. Fleshner, and P. Toren, “Switching from a gonadotropin-releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta-analysis”, CUAJ, vol. 14, no. 2, pp. 36–41, Jul. 2019.